STOCK TITAN

Zurn Elkay Water Solutions Corporation Form 4 Filings

ZWS NYSE

Every Form 4 that Zurn Elkay Water Solutions Corporation (ZWS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ZWS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ZWS filings page.

Rhea-AI Summary

Zurn Elkay Water Solutions (ZWS) reported an insider transaction by Director Timothy J. Jahnke. On 10/29/2025, he sold 2,100 shares of common stock at $50 per share (transaction code S) pursuant to a Rule 10b5-1 plan. After the sale, he beneficially owns 306,864 shares directly and 180,000 shares indirectly through an irrevocable trust.

Rhea-AI Summary

Zurn Elkay Water Solutions (ZWS) director reported an acquisition of 509 shares of common stock on 10/15/2025 at $46.67 per share, according to a Form 4 filing. The filing lists the transaction as code A, reflecting an award tied to director compensation.

The award was described as director fees paid in restricted stock units that vested immediately, with payout deferred until six months after the director’s service ends. Following the transaction, the director beneficially owned 57,841 shares, held directly.

Rhea-AI Summary

Zurn Elkay Water Solutions (ZWS) reported an insider equity transaction by a director. On 10/15/2025, the director acquired 643 shares of common stock at a price of $46.67.

Following the transaction, the director beneficially owned 116,097 shares, held directly. According to the footnote, the shares reflect payment of director fees in restricted stock units that vested immediately, with settlement deferred until six months after the director’s cessation of board service.

Rhea-AI Summary

Zurn Elkay Water Solutions (ZWS) reported a director transaction on Form 4. Director Peggy Troy acquired 590 shares of common stock on 10/15/2025, coded A for an acquisition, at a stated price of $46.67 per share. Following the transaction, Troy beneficially owned 61,035 shares, held directly.

The footnote explains this was a payment of director fees in restricted stock units that vested immediately, with settlement deferred until six months after the director’s cessation of service.

Rhea-AI Summary

Zurn Elkay Water Solutions (ZWS) disclosed a director equity transaction. On 10/15/2025, Director David C. Longren acquired 590 shares of common stock at $46.67, bringing his directly held stake to 94,128 shares. The award reflects payment of director fees in restricted stock units that vested immediately and will be settled six months after his service as a director ends.

Rhea-AI Summary

Zurn Elkay Water Solutions (ZWS) reported an insider transaction by Director Thomas D. Christopoul. On 10/15/2025, he acquired 617 shares of common stock at $46.67 per share. The filing notes the acquisition reflects payment of director fees in restricted stock units that vested immediately, with payout deferred until six months after his cessation of service as a director.

Following the transaction, he beneficially owned 113,662 shares, held directly. The filing was made by one reporting person.

Rhea-AI Summary

Zurn Elkay Water Solutions (ZWS) reported a Form 4 showing a director acquired 509 shares of common stock on 10/15/2025 at $46.67.

The filing states the acquisition reflects payment of director fees in restricted stock units that vested immediately, with settlement occurring six months after the director’s service ends.

After the transaction, the reporting person beneficially owned 16,636 shares, held directly.

Rhea-AI Summary

Timothy J. Jahnke, a director of Zurn Elkay Water Solutions Corp (ZWS), sold 2,156 shares of the issuer's common stock on 09/16/2025 under a Rule 10b5-1 plan at a weighted average price of $47.54 per share. Following the reported transaction, Mr. Jahnke directly beneficially owned 308,964 shares and indirectly beneficially owned 180,000 shares held by an irrevocable trust. The Form 4 was signed under power of attorney on 09/18/2025 and notes the sale was executed in multiple trades at prices ranging from $47.50 to $47.62.